(Q38174213)

30 August 2017

title

Biomarkers in atrial fibrillation: an overview (English)

1 reference

30 August 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Francisco Marín

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

5

G Y H Lip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

J A Vílchez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

D Hernández-Romero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Valdés

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

22 December 2013

1 reference

International Journal of Clinical Practice

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

434-443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372915%20AND%20SRC:MED&resulttype=core&format=json

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Effect of atrial fibrillation on atrial refractoriness in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Atrial fibrillation and heart failure: natural history and pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Inflammation in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Role of inflammation and oxidative stress in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Biomarkers in atrial fibrillation: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Is atrial fibrillation an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

The evolving role of C-reactive protein in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Relation of multiple inflammatory biomarkers to incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Interleukin 6 and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

D-dimer level influences thromboembolic events in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Circulating microparticles: new insights into the biochemical basis of microparticle release and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

The role of resistin as a regulator of inflammation: Implications for various human pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Circulating adiponectin levels in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

The prognostic role of the adiponectin levels in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Relation of atrial fibrillation to glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

β-Trace protein: from GFR marker to cardiovascular risk predictor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304

Bleeding risk assessment and management in atrial fibrillation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12304